Hypertension, Pulmonary: all 1,119 studies

Page 5 of 12. Open to participants first (236), then studies with results posted, then the rest; newest registration first within each.

• Bosentan in Patients With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH)CompletedNCT00319111Phase 3Results posted
• The "VISION" Trial: Ventavis Inhalation With Sildenafil to Improve and Optimize Pulmonary Arterial HypertensionTerminatedNCT00302211Phase 3Results posted
• Simvastatin as a Treatment for Pulmonary HypertensionCompletedNCT00180713Phase 1/2Results posted
• The Efficacy and Safety of Sildenafil Citrate Used in Combination With Intravenous Epoprostenol in PAHCompletedNCT00159861Phase 3Results posted
• Clinical Investigation Into Inhaled Treprostinil Sodium in Patients With Severe Pulmonary Arterial Hypertension (PAH)CompletedNCT00147199Phase 3Results posted
• Chronic Sildenafil for Severe Diaphragmatic HerniaTerminatedNCT00133679Phase 4Results posted
• Early Postoperative Triple Targeted Therapy in Patients With CHD-PAH in the "Grey Zone"CompletedNCT07844213Not applicable
• Cardiorespiratory Assessment Prior to Scoliosis Surgery: a 10-year Experience at a Specialized Scoliosis CenterActive, not recruitingNCT07760441
• Comparison of Dynamic Compliance and Airway Resistance in Pressure-Controlled Versus Volume-Controlled Ventilation in Children Undergoing Corrective Heart SurgeryCompletedNCT07754591Not applicable
• Multimodality RV Phenotyping for Risk Stratification and Short-Term Outcomes in Group 1 PAHActive, not recruitingNCT07667673
• Infusion of Allogeneic Stromal Mesenchymal Stem Cells From Wharton´s Jelly in Patients With Diffuse Cutaneous Systemic Sclerosis With Refractory Pulmonary Involvement to TreatmentCompletedNCT07542067Phase 1/2
• Non-Invasive and Invasive Assessment of Heart Filling PressureCompletedNCT07512310
• Sildinafil in Pulmonary Hypertension-Rheumatic Chronic Valvular Disease(RCT)CompletedNCT07462260Phase 2/3
• Dynamic Mixed Learning Module in Pulmonary Hypertension PatientsCompletedNCT07429552Not applicable
• Impact Of Using LevosemidanVersus DobutamineOn Right Ventricular Function In AdultPatients Undergoing Elective Valve Replacement SurgeryCompletedNCT07416331
• Circulating Activin-A and FSTL3 in Precapillary Pulmonary HypertensionActive, not recruitingNCT07253363Not applicable
• Study of JK07 in Patients With Heart Failure and WHO Group 2 Combined Post- and Pre-Capillary Pulmonary HypertensionWithdrawnNCT07221513Phase 2
• Etude PROTECT : Prognostic Role of Tapse Evaluation in Children's bronchioliTisCompletedNCT07209956Not applicable
• Londrina Activities of Daily Living Protocol in Pulmonary HypertensionCompletedNCT07206173
• Effectiveness and Tolerance of Respiratory Rehabilitation in Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary DiseaseCompletedNCT07202793
• Is the Two-minute Step Test an Alternative to the Six-minute Walk Test in Pulmonary Hypertension?Active, not recruitingNCT07193173
• Efficacy and Safety of Seralutinib in Adult Subjects With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)SuspendedNCT07181382Phase 3
• The Risk of Adverse Pregnancy Outcomes for Long-term Exposure to Air Pollution in Pregnant Patients With Pulmonary HypertensionCompletedNCT07164157
• A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have Previously Participated in a Clinical Study With PF-07868489Active, not recruitingNCT07073820Phase 2
• Construction of Clinical Diagnostic Model for Pulmonary HypertensionCompletedNCT06979011
• Non-Invasive Lung Water Monitoring in Pulmonary HypertensionCompletedNCT06942871
• Vardenafil Vs Sildenafil for the Treatment of Pulmonary Hypertension of the NewbornCompletedNCT06860399Phase 1/2
• Extension Study of Sotatercept in People With Pulmonary Hypertension (MK-7962-023)Active, not recruitingNCT06814145Phase 2
• Identification of the Risk of Remote Pulmonary Hypertension in Preterm Births.CompletedNCT06800300
• Pediatric Ventricle Function Assessment StudyCompletedNCT06739057
• The Role of miRNA in Group 3 Pulmonary HypertensionActive, not recruitingNCT06714136
• Melatonin for Pulmonary Hypertension in Full Term NeonatesCompletedNCT06685679Phase 3
• Wearable Assessment of Thoracic, Cardiac Health and Exercise Performance TrialCompletedNCT06671171
• A Study of LCAR-AIO in Subjects With Relapsed/Refractory Systemic Lupus ErythematosusCompletedNCT06653556Early Phase 1
• A Study of Mosliciguat in PH-ILDActive, not recruitingNCT06635850Phase 2
• A Study of TX000045 in Patients With Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction (the APEX Study)Active, not recruitingNCT06616974Phase 2
• Lung Hyperinflation and Response to Pulmonary Vasodilator TherapyCompletedNCT06613321
• Subcutaneous Treprostinil as a Bridge to Lung Transplantation in Severe Pulmonary Hypertension: A Single-Arm Retrospective StudyCompletedNCT06605326Phase 4
• Study of HS135 in Obese Patients With Pulmonary Hypertension and Heart Failure With Preserved Ejection FractionTerminatedNCT06581159Phase 1
• Right Ventricular Function in Patients Taking CarfilzomibCompletedNCT06568952
• Efficacy of Milrinone With Sildenafil in Persistent Pulmonary Hypertension in ChildrenCompletedNCT06562036Not applicable
• Highlanders With High Altitude Pulmonary Hypertension (HAPH), Pulmonary Arterial Pressure (PAP) Assessed at 3200m With and Without Supplemental Oxygen Therapy (SOT)CompletedNCT06489756Not applicable
• Highlanders With High Altitude Pulmonary Hypertension (HAPH), 6 Minute Walk Distance (6MWD) Assessed at 3200m With and Without Supplemental Oxygen Therapy (SOT)CompletedNCT06489743Not applicable
• High Altitude Residents With High Altitude Pulmonary Hypertension (HAPH), SDB Assessed at HA (3200 m) vs LA (760 m)CompletedNCT06489717Not applicable
• High Altitude (HA) Residents With High Altitude Pulmonary Hypertension (HAPH), Pulmonary Artery Pressure (PAP) Assessed at HA (3200 m) vs LA (760 m)CompletedNCT06489704Not applicable
• High Altitude Residents With High Altitude Pulmonary Hypertension (HAPH), 6MWT Assessed at High Altitude (3200m) vs Low Altitude (760m)CompletedNCT06489691Not applicable
• Exercise Performance on Ambient Air vs. Low-Flow Oxygen Therapy in Pulmonary Vascular Disease (PVD)CompletedNCT06384534Not applicable
• A Feasibility Study of Supplemental Oxygen to Improve Pulmonary Hypertension in People With Intradialytic HypoxemiaWithdrawnNCT06327373Phase 1/2
• Hemodynamic Effects of Apnoeic Oxygenation With High-flow Nasal Oxygen in Adults Undergoing Laryngeal SurgeryCompletedNCT06316063Not applicable
• Assessment of the Cerebral Perfusion During the Period of Deep Hypothermia at 18°C in Patient Undergoing Pulmonary Endarterectomy Surgery.Active, not recruitingNCT06250374Not applicable
• Contrast Enhanced PA Pressure MeasurementsCompletedNCT06240871
• Cardiac Dysfunction in Critically Ill Covid-19 PatientsCompletedNCT06197256
• Pulmonary Hypertension on Prognosis of Acute Myocardial Infarction Patients With Reduced Left Ventricular FunctionCompletedNCT06186713
• Hyperoxia During Pulmonary Rehabilitation in Chronic Lung Disease - Does it Matter?CompletedNCT06174207Not applicable
• ADOPT: Improving Diagnosis of Pulmonary Hypertension With AI and EchoWithdrawnNCT06145880
• Xenon MRI in Stable Pulmonary Hypertension (Jupiter AUGEAN)WithdrawnNCT06122922Phase 2
• High Altitude (HA) Residents With Pulmonary Vascular Diseseases (PVD), Pulmonary Artery Pressure (PAP) Assessed at HA (2840m) vs Sea Level (LA)Active, not recruitingNCT06092424Not applicable
• HA Residents With PVD, Pulmonary Artery Pressure (PAP) Assessed at HA (2840m) With and Without Supplemental Oxygen Therapy (SOT)Active, not recruitingNCT06084559Not applicable
• Hemodynamic Effect of Nasal High-flow in Patients Suspected or Followed for a Precapillary Pulmonary HypertensionStatus unknownNCT06079151Not applicable
• HA Residents With PVD, SDB Assessed at HA (2840m) vs LA (Sea Level)Active, not recruitingNCT06072417Not applicable
• Incidence of Acute Kidney Injury and Risk Factors in Newborns With Congenital Diaphragmatic HerniaCompletedNCT06050525
• A Study to Learn How Safe the Study Treatment BAY2701250 is, How it Affects the Body and How it Moves Into, Through and Out of the Body in Healthy Male Participants When a Single Amount is Given as an Injection Into the Vein (Intravenous Infusion) or Under the Skin (Subcutaneous Injection)CompletedNCT06048120Phase 1
• Improving Pulmonary Hypertension Screening by EchocardiographyActive, not recruitingNCT06038149
• Clinical Characteristics and Outcomes of Patients With Pulmonary Hypertension Associated Right Heart FailureActive, not recruitingNCT06023134
• High Altitude (HA) Residents With Pulmonary Vascular Diseases (PVD), 6 Minute Walk Distance (6MWD) Assessed at 2840m (HA) With and Without Supplemental Oxygen Therapy (SOT)Active, not recruitingNCT06003244Not applicable
• Study for Evaluation of Safety and Efficacy of PADN to Treat Combined Post- and Pre- Capillary Pulmonary Hypertension Associated With Chronic Heart Failure（PADN-CpcPH-PILOT）CompletedNCT05996562Not applicable
• HA Residents With PVD, 6MWD Assessed at HA (2840m) vs LA (Sea Level)Active, not recruitingNCT05996302Not applicable
• Pulmonary Artery Pressure in COVID-19 SurvivorsCompletedNCT05993338Not applicable
• LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEFActive, not recruitingNCT05983250Phase 3
• Pulmonary Artery DenerVation Clinical Study Using the Gradient Denervation System in Heart Failure Patients With Pulmonary HypertensionActive, not recruitingNCT05951166Not applicable
• Acute Responses of Active Video Games and Traditional Exercise Program in in Patients With Pulmonary HypertensionCompletedNCT05901168Not applicable
• Early Feasibility Study Evaluating the 3P-100 Device in Subjects With PH-ILDActive, not recruitingNCT05867914Not applicable
• Prognostic Value of Estimated Plasma Volume in Pulmonary HypertensionCompletedNCT05861479
• PIMR and Pulmonary Vascular DiseaseCompletedNCT05843461
• Inhaled Versus Intravenous Milrinone for Patients Undergoing Mitral Valve Replacement SurgeryCompletedNCT05838846Phase 2/3
• Integrating ePReBMs From Phoenix in Respiratory DiseasesTerminatedNCT05827302Not applicable
• A Trial to Evaluate the Safety and Efficacy of Pulmonary Artery Denervation for the Treatment of Pulmonary Hypertension Associated With Left Heart FailureActive, not recruitingNCT05824923Phase 3
• Novel Index (PIMR) in PAHCompletedNCT05812976
• Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier DetectionCompletedNCT05776225
• StratosPHere (Non-interventional Study)CompletedNCT05767918
• A Study to Assess Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Hypertension Associated With Pulmonary FibrosisStatus unknownNCT05747508Phase 2
• A Study of AZD3427 in Participants With Heart Failure and Pulmonary Hypertension Group 2CompletedNCT05737940Phase 2
• A Study of Macitentan in Children Below 2 Years of AgeWithdrawnNCT05731492Phase 1
• The Effect of Pituitrin on the Patients With Pulmonary Hypertension Undergoing Cardiac SurgerySuspendedNCT05727618Not applicable
• Self-help Booklets for Depression in Adults With Pulmonary Hypertension.CompletedNCT05726669Not applicable
• Correlation of Right Atrial Strain With Pulmonary Hypertension, Right Ventricular Function And Outcome In Pediatric PatientsStatus unknownNCT05699681
• Exercise Therapy After Pulmonary Thromboendarterectomy or Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary HypertensionWithdrawnNCT05693779Not applicable
• Comparison of Different Cardiac Output Measurement Methods in Patients Undergoing Right Heart CatheterizationStatus unknownNCT05665218
• An Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) for Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)CompletedNCT05649722Phase 2/3
• TrEatment Approach in the Multimodal Era RegistryActive, not recruitingNCT05629052
• Frespaciguat (MK-5475) INSIGNIA-PH-COPD: A Study of the Efficacy and Safety of Frespaciguat (an Inhaled sGC Stimulator) in Adults With PH-COPDActive, not recruitingNCT05612035Phase 2
• A Healthy Volunteer Study Evaluating the the Safety, Tolerability, and Pharmacokinetics of RT234CompletedNCT05567367Phase 1
• Postoperative Morbidity / Mortality Rates of Patients With Pulmonary HypertensionStatus unknownNCT05565911
• Genetics of Pulmonary HypertensionStatus unknownNCT05550389
• Pulmonary Hypertension and ArrhythmiaCompletedNCT05496504
• ADAMTSL4 in Idiopathic Pulmonary Hypertension and CTEPHCompletedNCT05478226
• Network Medicine Approaches to Classify Heart Failure With PReserved Ejection Fraction by Signatures of DNA Methylation and Point-of-carE Risk calculaTors (PRESMET)CompletedNCT05475028
• Predictors of Pulmonary Hypertension in Patients With Hypersensitivity PneumonitisCompletedNCT05458635Not applicable
• Evaluation of the Strength of Handgrip in Patients With Pulmonary Artery HypertensionStatus unknownNCT05447390Not applicable
• A Dose Escalation Study to Evaluate the Effect of RT234 in Subjects With Pulmonary Arterial HypertensionCompletedNCT05343637Phase 2

← Hypertension, Pulmonary overview